 Abacavir/lamivudine/zidovudine was approved for use in the United States and the European Union in 2000.In December 2013, Lupin Limited launched a generic version of abacavir/lamivudine/zidovudine.As of 2016 the wholesale cost for a typical month of medication in the United States is more than US$669.30.